Osaic Holdings’s Elicio Therapeutics ELTX Stock Holding History

Osaic Holdings’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-233	Closed	-$2K	–	7245
2022 Q3	$2K	Hold	233	–	–	﹤0.01%	6758
2022 Q2	$3K	Hold	233	–	–	﹤0.01%	6713
2022 Q1	$5K	Hold	233	–	–	﹤0.01%	6467
2021 Q4	$7K	Hold	233	–	–	﹤0.01%	6460
2021 Q3	$23K	Buy	+233	New	+$25.2K	﹤0.01%	5669

Other funds holding ELTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings's ELTX Position: Q4 2022 in Review

Osaic Holdings sold out of Elicio Therapeutics (ELTX) in Q4 2022, closing a stake of 233 shares — an estimated $2K sold.

Osaic Holdings first reported a position in ELTX in Q3 2021 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 30 funds tracked by Wall St. Rank hold ELTX as of Q4 2022.

Osaic Holdings reported no remaining Elicio Therapeutics position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 233 Elicio Therapeutics shares in Q4 2022, an estimated $2K.
Osaic Holdings first reported a position in Elicio Therapeutics in Q3 2021 and held it in 5 quarters.
Osaic Holdings's Elicio Therapeutics position peaked at $23K in Q3 2021.
30 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.